Search Results

As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.

Sanford Burnham Prebys announced plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology.

Rapid Technologies, a Premier ServiceNow partner, recently completed a ServiceNow modernization project for San Diego-based Sanford Burnham Prebys Medical Discovery Institute.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Cancers from a team of cancer researchers primarily at the NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute and Scripps MD Anderson in La Jolla, California.

Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California San Diego School of Medicine received a $9-million grant from the National Institute on Drug Abuse at the National Institutes of Health.

Cerecor Inc. today announced that it has entered into an exclusive license agreement with Sanford Burnham Prebys for the worldwide development and commercialization of an immune checkpoint program.

Viscient Biosciences announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a liver fibrosis phenotype in a 3D human tissue model of MASH demonstrating strong comparability to the native disease by multiple measures.

Non-invasive nose-to-brain delivery system expands treatment options for patients with